<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Basic Research in Medical Sciences</title>
<title_fa>مجله ی تحقیقات پایه در علوم پزشکی</title_fa>
<short_title>jbrms</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jbrms.medilam.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2383-0506</journal_id_issn>
<journal_id_issn_online>2383-0972</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/jbrms</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>12</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Comparison of the Effect of 2% Finasteride Topical Solution Versus 5% Minoxidil Topical Solution in the Treatment of Androgenic Alopecia in Men: A Quasi-Experimental Study</title>
	<subject_fa>Dermatology</subject_fa>
	<subject>Dermatology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:9pt&quot;&gt;&lt;span minion=&quot;&quot; pro=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;Introduction&lt;/b&gt;: About 50% of men experience different types of hair loss by the age of 50. To treat this problem, based on the Food and Drug Administration (FDA), the aim of this study was to compare the effect of 2% topical finasteride solution versus 5% topical minoxidil solution in the treatment of androgenic alopecia in men.&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:9pt&quot;&gt;&lt;span minion=&quot;&quot; pro=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;Materials &amp; Methods&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;The study was quasi-experimental and was conducted on 194 men with the initial complaint of hair loss in the dermatology clinic of Imam Reza Hospital in Ardabil during September 2020 and June 2021, who were randomly divided into two equal groups by the random block method. Data were collected by a checklist and then analyzed by using descriptive statistical methods in SPSS V.21. The significance level was considered less than 0.05.&lt;span lang=&quot;FA&quot; dir=&quot;RTL&quot; style=&quot;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:9pt&quot;&gt;&lt;span minion=&quot;&quot; pro=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;b&gt;Results&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: &amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;In the minoxidil and finasteride group, the pull test was negative in 17.7% and 24.5% of patients during the first month, respectively. In 2-3% of patients in the minoxidil group, tension headache and scalp irritation were reported, but no such side effects were found in the finasteride group. In general, reduction of hair loss and hair regrowth during six months of continuous use of the drug was observed in 65.6% of patients in the minoxidil group and 85.4% of patients in the finasteride group.&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:97%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;Conclusion&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:97%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;: &amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:11.0pt&quot;&gt;&lt;span style=&quot;line-height:97%&quot;&gt;&lt;span calibri=&quot;&quot; style=&quot;font-family:&quot;&gt;Topical solutions of finasteride and minoxidil were effective and safe in the treatment of mild to severe androgenetic alopecia in men.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Alopecia, Finasteride, Minoxidil, Men</keyword>
	<start_page>43</start_page>
	<end_page>51</end_page>
	<web_url>http://jbrms.medilam.ac.ir/browse.php?a_code=A-10-914-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Majid</first_name>
	<middle_name></middle_name>
	<last_name>Rostami-Mogaddam </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rostamimajid665@gmail.com</email>
	<code>10031947532846008298</code>
	<orcid>10031947532846008298</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Dermatology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Leyla</first_name>
	<middle_name></middle_name>
	<last_name>Rezaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>l.rezayi@gmail.com</email>
	<code>10031947532846008299</code>
	<orcid>10031947532846008299</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Dermatology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Afrouz</first_name>
	<middle_name></middle_name>
	<last_name>Mardi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a.mardi@gmail.com</email>
	<code>10031947532846008300</code>
	<orcid>10031947532846008300</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of public Health, School of Health, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Amir </first_name>
	<middle_name></middle_name>
	<last_name>Sadrinia</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846008301</code>
	<orcid>0009-0000-1291-7914</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
